Prognostic study of chondrosarcoma by subtype (Conventional Grade 1, Grades 2 and 3, Periosteal, Clear cell, Mesenchymal, and Dedifferentiated types) - Valutazione prognostica dei diversi sottotipi di Condrosarcoma (Convenzionale Grado 1, Gradi 2 e 3...

Title

Code

Pro-Condro

Type

Osservazionale

Start Year

2026

Status

In Corso

Principal Investigator

051-6366103

costantino.errani@ior.it

Errani Costantino, MD, PhD

3rd Orthopaedic and Traumatologic Clinic prevalently Oncologic

Operational unit that carry out the study

complex unit

Clinica Ortopedica e Traumatologica III a prevalente indirizzo Oncologico

Director

Donati Davide Maria, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. Pro-Condro

Friday 14 August 2026, 13:36

PG0010656_2026_Stampa_unica.pdf

Attachment

Informativa Privacy

Friday 14 August 2026, 13:34

8_informativa_dati_ce-avec_v.1.0.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

Prognostic study of chondrosarcoma by subtype (Conventional Grade 1, Grades 2 and 3, Periosteal, Clear cell, Mesenchymal, and Dedifferentiated types) - Valutazione prognostica dei diversi sottotipi di Condrosarcoma (Convenzionale Grado 1, Gradi 2 e 3...

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in